Notify me when Brii Biosciences Ltd files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ANTX | AN2 THERAPEUTICS, INC. | Common Stock, $0.00001 par value per share | 3.1% | $1.2M | 927K | Brii Biosciences Limited | 31 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|